Brookfield Asset Management and CDPQ Acquire Antylia Scientific from GTCR
May 28, 2025
Brookfield Asset Management's private equity business, together with Brookfield Business Partners and CDPQ, completed the acquisition of Antylia Scientific from GTCR for approximately $1.3–$1.34 billion. Antylia, headquartered in Vernon Hills, Illinois, is a diversified life‑sciences tools manufacturer and distributor serving biopharma, clinical diagnostics and environmental testing markets; the transaction represents a PE exit after a decade of GTCR partnership and transformational growth.
- Buyers
- Brookfield Asset Management (private equity business), Brookfield Business Partners, CDPQ (Caisse de dépôt et placement du Québec)
- Targets
- Antylia Scientific
- Sellers
- GTCR
- Industry
- Medical Devices
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.